AI and a Hybrid 3D Printer Just Built Functional Blood Vessel Networks in a Lab

Researchers at the University of Notre Dame and Harvard Medical School published results from a hybrid bioprinting system that produces vascularized tissue scaffolds — structures with functional blood vessel networks — using AI-guided parameter optimization. The result is not a prototype of transplantable tissue; it is a proof that the engineering approach works at the channel scale needed for biological function.

The Technical Problem They Solved

Bioprinted tissue fails at scale because of vascularization. Print a block of cells larger than a few hundred microns and the interior cells die — oxygen and nutrients cannot diffuse through the full thickness without vascular networks delivering them. The body solves this with capillaries at 5–10 microns in diameter embedded throughout every tissue. Replicating that structure is the foundational problem in tissue engineering.

Previous bioprinting approaches could create larger scaffold channels (hundreds of microns) or smaller surface features, but not functional channels at the capillary scale that could sustain cell viability through the full thickness of printed tissue.

What the System Does

The Notre Dame/Harvard team used a hybrid printer combining two complementary approaches:

Extrusion-based printing for the macroscale scaffold structure — the overall architecture of the tissue with its larger channels and geometric organization.

Aerosol jet printing for the fine-scale vasculature — depositing material in channels from 5–6 microns (near capillary scale) to 200 microns, spanning the range needed to connect the macro scaffold to cellular-scale delivery.

The AI component is Bayesian optimization applied to the printing parameters — the pressure settings, nozzle geometry, material viscosity, and deposition patterns that determine whether printed features form correctly. Bayesian optimization is a structured approach to exploring a high-dimensional parameter space: each printing run produces data; the model updates its estimate of which parameter regions are likely to produce the desired outcome; the next run tests the highest-value unexplored region. Eight optimization rounds were sufficient to identify parameters that produced functional channel formation.

What They Observed

After printing, endothelial cells — the cells that line the interior of blood vessels in living tissue — were introduced to the scaffold. They attached to the printed channel walls and formed continuous linings. Fluid was pumped through the networks and flowed successfully through the channels without structural failure.

These are the two critical functional validations: biological compatibility (cells attach and behave as they do in native vasculature) and mechanical integrity (the channels hold structure under fluid pressure).

The research is backed by $2.6 million in NIH funding, which provides both external validation of the approach’s scientific merit and the resources needed for multi-year optimization work.

Near-Term vs. Long-Term Applications

The researchers identify two distinct application timelines. Near-term, the most immediate utility is in drug testing and toxicology — vascularized tissue models that more accurately represent how drugs and toxic compounds behave in living tissue. The current standard for pre-clinical drug testing uses 2D cell cultures or animal models, both of which have documented limitations in predicting human outcomes. Vascularized 3D tissue models address some of those limitations without requiring animal subjects.

Long-term, the goal is transplantable tissue — printed constructs that could replace damaged tissue in patients. This requires not just functional vasculature but the ability to integrate with the patient’s own circulatory system and survive implantation. That is a substantially harder problem and remains years of further research away.

Source: 3DPrint.com

Content created with AI assistance and reviewed for accuracy.